These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22555531)

  • 1. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
    Solomides CC; Birbe RC; Nicolaou N; Bagley D; Bibbo M
    Acta Cytol; 2012; 56(3):285-8. PubMed ID: 22555531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
    Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
    Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
    Puripat N; Loharamtaweethong K
    Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.
    Duregon E; Cassenti A; Pittaro A; Ventura L; Senetta R; Rudà R; Cassoni P
    Neuro Oncol; 2015 May; 17(5):663-9. PubMed ID: 25646026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study.
    Veras E; Malpica A; Deavers MT; Silva EG
    Int J Gynecol Pathol; 2009 Jul; 28(4):316-21. PubMed ID: 19483635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.
    Gunia S; Kakies C; Erbersdobler A; Koch S; May M
    J Clin Pathol; 2012 Aug; 65(8):715-20. PubMed ID: 22554964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of mitosis counting by automated phosphohistone H3 (PHH3) digital image analysis in a breast carcinoma tissue microarray.
    Dessauvagie BF; Thomas C; Robinson C; Frost FA; Harvey J; Sterrett GF
    Pathology; 2015 Jun; 47(4):329-34. PubMed ID: 25938351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas.
    Schimming TT; Grabellus F; Roner M; Pechlivanis S; Sucker A; Bielefeld N; Moll I; Schadendorf D; Hillen U
    Am J Dermatopathol; 2012 May; 34(3):266-9. PubMed ID: 22197861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Phosphohistone H3 in Breast Cancer Grading.
    Cui X; Harada S; Shen D; Siegal GP; Wei S
    Appl Immunohistochem Mol Morphol; 2015; 23(10):689-95. PubMed ID: 25611243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens.
    Draganova-Tacheva R; Bibbo M; Birbe R; Daskalakis C; Solomides C
    Acta Cytol; 2013; 57(3):291-5. PubMed ID: 23635399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
    Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA
    Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.
    Casper DJ; Ross KI; Messina JL; Sondak VK; Bodden CN; McCardle TW; Glass LF
    Am J Dermatopathol; 2010 Oct; 32(7):650-4. PubMed ID: 20559123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
    Munari E; Fujita K; Faraj S; Chaux A; Gonzalez-Roibon N; Hicks J; Meeker A; Nonomura N; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2668-76. PubMed ID: 24074531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast.
    Ginter PS; Shin SJ; Liu Y; Chen Z; D'Alfonso TM
    Hum Pathol; 2016 Mar; 49():90-8. PubMed ID: 26826415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.
    Alkhasawneh A; Reith JD; Toro TZ; Ayed AO; Lu X; George TJ; Duckworth LV
    Am J Clin Pathol; 2015 Mar; 143(3):385-92. PubMed ID: 25696796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.
    Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN
    Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.
    Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA
    Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinoma.
    Nakashima S; Shiozaki A; Ichikawa D; Komatsu S; Konishi H; Iitaka D; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Otsuji E
    Anticancer Res; 2013 Feb; 33(2):461-7. PubMed ID: 23393337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.
    Ikenberg K; Pfaltz M; Rakozy C; Kempf W
    J Cutan Pathol; 2012 Mar; 39(3):324-30. PubMed ID: 22335591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.